A 50-year-old woman presents with symmetrical swelling and tenderness of the metacarpophalangeal and proximal interphalangeal joints for 3 months, morning stiffness lasting 90 minutes, and elevated inflammatory markers. Anti-CCP antibodies are positive. According to Canadian Rheumatology Association guidance, what is the preferred initial disease-modifying treatment?